🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-01
Trial ID
NCT01978093
Treatments Being Tested
The purpose of this study is to evaluate safety, to demonstrate lot-to-lot ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-18
Trial ID
NCT01000974
The purpose of this cohort study is to determine vaccine-specific rates of ...
Status
Completed
Location
Multiple Locations
Start Date
2010-02-08
Trial ID
NCT01129362
Treatments Being Tested
The aim of this this study is to confirm absence of immune interference bet...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06
Trial ID
NCT00334607
Treatments Being Tested
Pre-licensure studies of GSK Biologicals' PEDIARIX vaccine have shown it to...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00146835
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526
The purpose of this study is to assess if there is any immune interference ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-14
Trial ID
NCT03207750
Treatments Being Tested